Fulcrum Therapeutics Files Q1 2026 10-Q
Ticker: FULC · Form: 10-Q · Filed: Apr 27, 2026 · CIK: 0001680581
| Field | Detail |
|---|---|
| Company | Fulcrum Therapeutics, Inc. (FULC) |
| Form Type | 10-Q |
| Filed Date | Apr 27, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceutical
TL;DR
Fulcrum Therapeutics filed its 10-Q for Q1 2026. All systems go.
AI Summary
Fulcrum Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ending March 31, 2026. The filing details the company's financial status and operational updates. The company's mailing and business address is 26 LANDSDOWNE STREET, CAMBRIDGE, MA 02139.
Why It Matters
This filing provides investors with an update on Fulcrum Therapeutics' financial health and operational progress during the first quarter of 2026.
Risk Assessment
Risk Level: low — This is a standard quarterly report filing with no immediately apparent negative or positive financial indicators.
Key Numbers
- 2026-03-31 — Period End Date (The end date of the reporting period for this 10-Q.)
- 2026-04-27 — Filing Date (The date this 10-Q was officially filed with the SEC.)
Key Players & Entities
- Fulcrum Therapeutics, Inc. (company) — Filer of the 10-Q report
- 2026-03-31 (date) — Period of report for the 10-Q
- 2026-04-27 (date) — Filing date of the 10-Q
- 0001680581 (company) — CIK number for Fulcrum Therapeutics, Inc.
- 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 (address) — Mailing and Business Address for Fulcrum Therapeutics, Inc.
FAQ
What is the primary purpose of this filing?
This is a Form 10-Q, which is a quarterly report filed by Fulcrum Therapeutics, Inc. to provide an update on its financial performance and operations for the period ending March 31, 2026.
When was this 10-Q filed?
This 10-Q was filed on April 27, 2026.
What is Fulcrum Therapeutics' business address?
Fulcrum Therapeutics, Inc.'s business address is 26 LANDSDOWNE STREET, CAMBRIDGE, MA 02139.
What is the CIK number for Fulcrum Therapeutics, Inc.?
The CIK number for Fulcrum Therapeutics, Inc. is 0001680581.
What is the fiscal year end for Fulcrum Therapeutics?
The fiscal year end for Fulcrum Therapeutics is December 31 (1231).
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 27, 2026 regarding Fulcrum Therapeutics, Inc. (FULC).